Analysis of new treatments proposed for malignant pleural mesothelioma raises concerns about the conduction of clinical trials in oncology

MLA

Tomer Meirson, et al. Analysis of New Treatments Proposed for Malignant Pleural Mesothelioma Raises Concerns about the Conduction of Clinical Trials in Oncology. Jan. 2022. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....4e8e9df4eac5be126e85b7eb4c91243a&authtype=sso&custid=ns315887.

APA

Tomer Meirson, Valerio Nardone, Francesca Pentimalli, Gal Markel, David Bomze, Maria D’Apolito, Pierpaolo Correale, Antonio Giordano, Luigi Pirtoli, Camillo Porta, Steven G Gray, & Luciano Mutti. (2022). Analysis of new treatments proposed for malignant pleural mesothelioma raises concerns about the conduction of clinical trials in oncology.

Chicago

Tomer Meirson, Valerio Nardone, Francesca Pentimalli, Gal Markel, David Bomze, Maria D’Apolito, Pierpaolo Correale, et al. 2022. “Analysis of New Treatments Proposed for Malignant Pleural Mesothelioma Raises Concerns about the Conduction of Clinical Trials in Oncology,” January. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....4e8e9df4eac5be126e85b7eb4c91243a&authtype=sso&custid=ns315887.